Arax Advisory Partners’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$317K Buy
790
+759
+2,448% +$269K ﹤0.01% 1939
2026
Q1
$10K Sell
31
-445
-93% -$133K ﹤0.01% 2436
2025
Q4
$123K Sell
476
-27
-5% -$6.15K ﹤0.01% 1243
2025
Q3
$114K Buy
503
+443
+738% +$90.8K ﹤0.01% 1489
2025
Q2
$12.5K Sell
60
-21
-26% -$4.04K ﹤0.01% 1866
2025
Q1
$15.8K Sell
81
-31
-28% -$6.4K ﹤0.01% 1399
2024
Q4
$25.3K Hold
112
﹤0.01% 1123
2024
Q3
$23.3K Buy
112
+74
+195% +$14.9K ﹤0.01% 1023
2024
Q2
$7.15K Buy
+38
New +$7.04K ﹤0.01% 1421

Other funds holding MSGS

Arax Advisory Partners's MSGS Position: Q2 2026 in Review

Arax Advisory Partners increased its Madison Square Garden (MSGS) stake by 2,448% in Q2 2026, buying an estimated $269K and bringing the position to 790 shares worth $317K. The position accounts for ﹤0.01% of the portfolio, ranked #1939.

Arax Advisory Partners first reported a position in MSGS in Q2 2024 and has held it in 9 quarters since. 468 funds tracked by Wall St. Rank hold MSGS as of Q2 2026.

  • Arax Advisory Partners held 790 shares of Madison Square Garden worth $317K as of Q2 2026.
  • Arax Advisory Partners bought 759 Madison Square Garden shares in Q2 2026, an estimated $269K.
  • Madison Square Garden made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #1939 holding.
  • Arax Advisory Partners first reported a position in Madison Square Garden in Q2 2024 and has held it in 9 quarters since.
  • 468 funds tracked by Wall St. Rank held Madison Square Garden as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.